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Hernan A. Bazan, MD, Linda Le, MD, Melissa Donovan, MD, Tara Sidhom, RN, Taylor A. Smith, MD,
and W. Charles Sternbergh III, MD, New Orleans, La
Objective: Retrograde pedal access may allow the treatment of tibial occlusive lesions when standard endovascular tech-
niques fail. We aimed to analyze the outcomes in patients with chronic limb ischemia (Rutherford class IV and V) who
were not surgical candidates for a tibial bypass and had undergone an unsuccessful attempt at revascularization through
an antegrade access.
Methods:During a 3-year period, a retrograde pedal access was selectively chosen when a popliteal or tibial lesion could not
be crossed through an antegrade approach. Retrograde pedal access was performed under ultrasound guidance using a 4F
micropuncture coaxial sheath. All interventions were performed in a sheathless fashion using a 0.014- or 0.018-inch
“bareback” wire as support for a 2- or 2.5-mm balloon angioplasty catheter to cross and treat tibial chronic total oc-
clusions that could not be treated through an antegrade approach. Routine anticoagulation and dual-antiplatelet therapy
were used periprocedurally. Antegrade access was used to treat any lesion that required a stent placement after the
retrograde wire was snared and brought through the antegrade guidecatheter. Patient indications and comorbidities were
recorded. Outcomes analyzed were limb salvage rate, periprocedural complications, and mortality. Mean and standard
deviations were calculated. The Kaplan-Meier method was used to calculate limb salvage rates.
Results: A review of the 681 lower extremity angiograms in which a patient had an intervention from July 2010 through
December 2013 identiﬁed 13 patients (nine men) in whom a retrograde pedal access was performed (mean age, 71.4 6
12.4 years). Among these, diabetes was present in 10 of 13 (77%) and chronic renal insufﬁciency (stages II-V) in nine
(69%). Five (38%) had undergone contralateral amputation. Indications for a retrograde pedal revascularization were
Rutherford chronic limb ischemia class IV in two (15%) and class V in 11 (85%). Technical success rate was 69% (nine of
13). A variety of popliteal (two of 13) and tibial (13 of 13) vessels were treated with angioplasty alone (10 of 13) or
angioplasty/stent placement (three of 13) through a retrograde approach. The technical failures were due to inability to
cross the occlusion(s). Periprocedurally, there was one myocardial infarction but no local complications, worsening renal
insufﬁciency, or deaths. At a mean follow-up of 17.16 10.3 months, the limb salvage rate was 77% (10 of 13). There was
a high mortality rate of 23% (three of 13) on follow-up in this cohort, occurring at median 6 6 4 months.
Conclusions: Retrograde pedal access for limb salvage in high-risk patients is feasible and safe, with acceptable limb
salvage rates at intermediate follow-up. Appropriate candidates are those who have failed an antegrade intervention and
are poor candidates for a tibial bypass. Future studies should test whether this mode of revascularization has favorable
limb salvage rates in larger patient populations and seek to identify speciﬁc patient populations who will beneﬁt from this
technique. (J Vasc Surg 2014;60:375-82.)Patients with critical limb ischemia (CLI) require concomitant cardiovascular and pulmonary comorbidities
in-line revascularization in addition to optimal medical
therapy for limb salvage in cases of tissue loss. Generally,
patients with CLI have a poor survival compared with those
with intermittent claudication; at 1 year after presentation,
there is a 20% mortality, 30% undergo major amputation,
and only 45% are alive with both limbs.1,2 Infrainguinal
bypass remains the gold standard for treatment of CLI;
to date, no other mode of revascularization is comparable
to the excellent 5-year patency rates of popliteal-to-distal
bypass with vein.3 However, CLI patients often harborthe Section of Vascular/Endovascular Surgery, Department of
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bypass, particularly patients on dialysis. Out of this need,
endovascular revascularization has been used with inc-
reasing prevalence.4 Antegrade endovascular revasculariza-
tion can oftentimes be accomplished; however, a subset
of these patients with difﬁcult popliteal or tibial occlusive
lesions cannot be revascularized in an antegrade fashion,
even with the skills of an experienced interventionalist. In
these patients, a retrograde pedal access to establish in-line
ﬂow to the foot may be considered as an adjunctive endovas-
cular approach for revascularization in cases of limb salvage.
Since its initial description in 2003 by Botti et al5 and
Spinosa et al,6 several case reports7-19 and, more recently,
single-center series20-24 have described various aspects of
this technique. Intermediate follow-up and limb salvage
rates, however, are lacking in the literature. We describe
our experience with this technique during a 3-year period
in 13 patients with mean follow-up of 17.1 months.
METHODS
This was a retrospective case series performed with
Institutional Review Board approval at our institution.375
Fig 1. A, The pedal vessel can often be distinguished from the two surrounding veins by a “calciﬁed halo” (+).
B, Under ultrasound guidance, retrograde pedal access is obtained with a 4F micropuncture sheath (*) and a
0.018-inch hydrophilic-coated wire (Y). Attaching a copilot (arrow) permits injection through the side arm and
a retrograde angiogram. C, In a sheathless manner, a balloon catheter is brought in a “bareback” fashion retrograde
through the dorsalis pedis access.
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querying our institution’s procedural database for all lower
extremity angiograms with interventions and through a
prospectively maintained database (2012 to 2013; our in-
stitution’s Society for Vascular Surgery Vascular Quality
Initiative). Patient indications and comorbidities were
recorded. Outcomes analyzed were limb salvage rate, peri-
procedural complications (myocardial infarction, renal fail-
ure, bleeding), and mortality. Continuous variables are
expressed as mean 6 standard deviation. Kaplan-Meier
was used to calculate limb salvage rates using GraphPad
Prism software (GraphPad Software Inc, La Jolla, Calif).
Technique. Retrograde pedal access is obtained under
ultrasound guidance, using an S Series 7.5-MHz linear
probe (SonoSite Inc, Bothell, Wash), looking for a “calci-
ﬁed halo,” which is the heavily calciﬁed pedal artery, usually
accompanied by two pedal veins (Fig 1, A). The use of
larger probes may not be feasible. Light pressure applied
with the ultrasound transducer will compress the pedal
veins and reveal some pulsation in the target pedal artery,
even in patients with ankle-brachial indices <0.4 and
proximal popliteal and tibial occlusions. Color ﬂow may be
used to conﬁrm the pedal artery, although it is not
necessary.
After local anesthesia is established with 1% lidocaine, a
21-guage needle with an echogenic tip is entered into the
pedal artery under ultrasound guidance. The pedal artery is
often heavily calciﬁed in patients with diabetes mellitus or
chronic renal insufﬁciency, and hence, the operator can
often feel entry of the needle tip across the anterior wall
of the artery. Achieving entry in the ﬁrst try through a sin-
gle anterior wall access is important to avoid pedal artery
thrombosis.Next, a 4F 15-cm micropuncture coaxial introducer
catheter (Cook Medical, Bloomington, Ind) is used to
obtain a sheathless access, minimizing trauma to the pedal
vessel. As discussed earlier, a key potential disadvantage of
the retrograde pedal access is potential obliteration of the
runoff to the foot. To avoid this, a sheathless access is
used by next attaching a copilot bleed-back control valve
(Abbott, Santa Clara, Calif) to the 4F microcatheter with
an exchange-length 0.014-inch or 0.018-inch extra sup-
port hydrophilic-coated nitinol wire (Fig 1, B). The patient
is anticoagulated with heparin (80-100 U/kg), and an acti-
vated clotting time of 250 to 300 seconds is maintained
throughout the procedure.
Through the side arm of the copilot bleed-back control
valve, a retrograde angiogram is easily obtained and one
can get a road map of the lesion(s) to treat. To avoid vaso-
spasm, a solution of nitroglycerin and verapamil in heparin-
ized saline is used to ﬂush the sheathless microcatheter
access every 10 to 15 minutes. The components of this
mixture are verapamil hydrochloride, 2.5 mg; nitroglyc-
erin, 100 mg; and heparin, 2500 U in 50 mL 0.9% normal
saline. If the patient is hypotensive (systolic blood
pressure <90 mm Hg), verapamil may be omitted from
the mixture.
In our experience, open tibial access has not been
needed. Once the lesion(s) are identiﬁed, the microcath-
eter sheathless access is removed, and a low-proﬁle over-
the-wire small diameter (2- to 2.5-mm) Coyote ES balloon
(Boston Scientiﬁc, Natick, Mass) is used in a “bareback”
fashion as a support catheter (Fig 1, C). Under road map
ﬂuoroscopy, tibial lesion(s) are crossed in this retrograde
fashion and treated with balloon angioplasty. Should a
stent be necessary, traditional antegrade access is gained,
Fig 2. Representative transpedal angiogram shows a heavily diseased right anterior tibial (AT) artery that cannot be
accessed through a traditional antegrade approach in a patient with ischemic cardiomyopathy (10% ejection fraction and
a nonhealing right ﬁrst digit ulcer). A, A 5F angled glide catheter is placed in the below-knee popliteal artery through
antegrade access and a retrograde 0.014-inch hydrophilic wire in the proximal AT. B, Angiogram through the ante-
grade catheter demonstrates a heavily calciﬁed AT origin, which could not be crossed by antegrade access. C, Through
the retrograde access, the hydrophilic wire 0.014-inch wire easily crosses into the popliteal artery and is navigated into
the antegrade catheter. D, Angiogram demonstrates the near-occlusion in the AT origin and mid-AT disease, which is
(E) predilated, (F) revealing the stenotic origin disease, (G) followed by placement of a drug-eluting balloon-
expandable stent. Completion angiogram demonstrates (H) resolution of the AT origin disease, (I) in-line ﬂow to the
foot, and a patent dorsalis pedis artery access and ﬁlling of the pedal artery without any distal defects. Note the hy-
drophilic wire exiting from the dorsalis pedis in the foot, denoting the percutaneous access (arrows).
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lated inside of an antegrade catheter or may be snared
through the antegrade approach (Fig 2). Any lesion
requiring stent placement is treated from the antegrade
access.
After the intervention, gentle manual compression with
D-stat dry silver topical hemostat (Vascular Solutions, Min-
neapolis, Minn) is used for pedal access hemostasis, taking
care not to obliterate the runoff. We have found that 5 to
10 minutes is sufﬁcient.In some instances, retrograde wire passage through the
chronic total occlusion (CTO) into the true lumen may not
be possible and may result in placement of the hydrophilic
wire in a subintimal space. If not already established, tradi-
tional antegrade access is gained, and the antegrade wire is
brought into the subintimal space at the level of the occlu-
sion. A “double-balloon” technique12 to disrupt the dissec-
tion membrane with abutting balloons delivered from both
access sites can then be used to gain retrograde access
into the true lumen. Larger-diameter balloons are used
Table. Demographic characteristics, procedural details, and outcomes of the retrograde pedal cohort
Pt Age, years Sex DM
Stage V
CKD/HD
Contralateral
amputation Indication
Pedal
access
Technically
successful? Modality
Limb
salvage
Follow-up,
months
1 82 F Yes No No Tissue loss DP Yes PTAS Yes 24
2 53 M Yes Yes BKA Tissue loss PT Yes PTA Yes 35
3 57 M Yes Yes BKA Tissue loss PT Yes PTAS No 12
4 88 F No No No Tissue loss DP Yes PTAS Yes 30
5 59 M Yes Yes No Tissue loss PT No . No 25
6 84 M Yes No No Tissue loss PT No . Yes 30
7 67 M Yes No TMA Tissue loss PT Yes PTA Yes 26
8 72 M Yes No BKA Tissue loss DP Yes PTA Yes 8
9 64 M Yes Yes No Tissue loss DP Yes PTA Yes 5
10 87 M No No No Rest pain DP Yes PTA Yes 8
11 89 F No No No Tissue loss PT No . Yes 7
12 79 F Yes No BKA Tissue loss PT Yes PTA Yes 6
13 48 M Yes No No Rest pain PT No . Yesa 6
AKA, Above-knee amputation; BKA, below-knee amputation; CKD/HD, chronic kidney disease with hemodialysis; DM, diabetes mellitus; DP, dorsalis pedis
artery; F, female; M, male; Pt, patient; PT, posterior tibial artery; PTA, percutaneous angioplasty; PTAS, percutaneous angioplasty, followed by drug-eluting
stent placement; TMA, transmetatarsal.
aUnderwent pedal bypass for limb salvage.
Fig 3. Kaplan-Meier survival with standard error (dashed lines)
demonstrates avoidance of an ipsilateral below-knee or above-knee
amputation after retrograde pedal access.
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Inﬂation times of 1 minute at half nominal pressures may
be needed in these instances to seal the disrupted mem-
brane and avoid the need for stent placement. When a stent
is needed for ﬂow-limiting dissection or signiﬁcant (>30%
residual stenosis after angioplasty) disease, a drug-eluting
balloon-expandable stent is placed in the tibial vessel. All
patients undergoing pedal interventions (angioplasty alone
or with stent placements) are loaded with clopidogrel
(300 mg) postprocedure and maintained on dual antiplate-
let (aspirin, 81 mg) and statin therapy.
Patency of the revascularization was documented in the
initial ofﬁce postprocedure visit by pulse volume recordings
or arterial ultrasound, or both, for the nine patients who
were revascularized through a retrograde pedal access.
On long-term follow-up, however, the main outcome mea-
sure was limb salvage rate.
RESULTS
From July 1, 2010, through December 1, 2013, there
were 681 infrainguinal angiograms in which a patient had
an intervention performed by our group at our institution;
of these, 13 patients (nine men, four women) underwent a
retrograde pedal access. Demographics, indications, and
comorbidities are outlined in the Table. The 13 patients
in this cohort were a mean age of 71.4 6 12.4 years, and
diabetes was present in 10 (77%) and stages III to V
chronic renal insufﬁciency in nine (69%). Five patients
(38%) had undergone contralateral amputations: one pa-
tient had a previous contralateral transmetatarsal, three a
below-knee, and one an above-knee amputation. All pa-
tients had Rutherford chronic limb ischemia class IV,
ischemic rest pain, (15%; [two of 13]) or class V, minor tis-
sue loss (85% [11 of 13]).
The technical success rate was 69% (nine of 13). The
four technical failures were due to inability to cross the
CTO(s). A double-balloon technique was attempted in
four of the 13 patients and was successful in two of thefour attempts. Tibial vessels (nine of 13) were intervened-
on in this cohort, and two patients had concomitant popli-
teal interventions. There were six occlusions (two in the
popliteal artery and four in tibial vessels) and seven of 13
tibial stenoses. The mean lesion length was 6 cm (range,
2-12 cm). Interventions consisted of angioplasty alone (six
of nine), or angioplasty, followed by placement of a
balloon-expandable drug-coated stent (three of nine) for re-
sidual disease after angioplasty or ﬂow-limiting dissections.
One myocardial infarction occurred periprocedurally.
There were no local access complications or pedal vessel
thrombosis, worsening renal insufﬁciency, or deaths. At a
mean follow-up of 17.1 6 10.3 months, the limb salvage
rate was 77% (10 of 13; Fig 3). These patients had resolu-
tion of rest pain (one of 13) and healing of ulceration (nine
of 13). Of the four technical failures, there were three pa-
tients with tissue loss and one with rest pain. Two of the
JOURNAL OF VASCULAR SURGERY
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below-knee amputation, and in one patient, a small toe ul-
ceration healed at 7 months with aggressive local wound
care. The fourth patient with ischemic rest pain subse-
quently underwent a popliteal-to-tibial bypass for symptom
resolution. Overall, there was a high mortality rate on
follow-up in this cohort of 23% (three of 13) occurring
at median 6 6 4 months.
DISCUSSION
Treatment of tibial occlusive disease for patients with
limb-threatening ischemia (Rutherford chronic limb
ischemia class IV and V) remains a challenge in the high-
risk patient, particularly patients on dialysis and long his-
tory of diabetes, as in our series. Patients with peripheral
arterial disease conﬁned to the tibial vessels have a higher
incidence of limb loss, presumably due to more extensive
distal disease with poor runoff to the foot and severe
comorbidities precluding surgical bypass.25 Endovascular
treatment of patients with CLI who are poor bypass candi-
dates and who cannot be revascularized through an ante-
grade approach may be salvaged through a retrograde
pedal access, recanalization of the tibial or popliteal occlu-
sion(s), and deﬁnitive angioplasty, with or without stent
placement. Although no speciﬁc patient comorbidity
criteria were used, reasons for deeming a patient to not
be a bypass candidate were a failed chemical cardiac stress
test, history of ischemic cardiomyopathy with ejection frac-
tions of <20%, and patients on hemodialysis deemed to
have poor functional status. One of 13 patients in our series
subsequently underwent a popliteal-to-tibial bypass for
symptom resolution; in this individual, further cardiac
work-up after the failed retrograde pedal attempt demon-
strated he was a moderate risk for bypass.
There are certain advantages to the retrograde pedal
access:
1. The small diameter of tibial vessels (2-3 mm) may
help to increase the pushability of the wire and
microcatheter through the infrapopliteal occlusion.
2. Because collateral vessels usually arise in a caudal
angle, there is less likelihood of entering these side
branches through a retrograde approach.
3. Frequently, the most difﬁcult portion of an infrapo-
pliteal CTO is the proximal cap/segment. In
contrast, the distal portion is often softer, and gain-
ing access through it is often easier.
4. Finally, this approach may have a safety advantage in
morbidly obese patients or patients with a hostile or
infected groin, in whom an antegrade femoral
approach may not be technically feasible.
Similarly, there are potential disadvantages to a retro-
grade pedal approach to consider:
1. The small diameter of the tibial vessels, particularly in
women, could make them particularly prone to vaso-
spasm and possible thrombus formation.2. Multiple sticks should be avoided because this could
result in vessel spasm, thrombosis, and risk oblitera-
tion of the runoff to the foot and worsening of the
presenting symptomatology.
3. Finally, this is not a routinely use approach, and the
unfamiliarity by operating room or catheterization
technicians may make this approach especially chal-
lenging in already difﬁcult cases.
Taken together, in speciﬁc cases of patients with CLI
who are not tibial bypass candidates and who cannot be
revascularized through an antegrade approach, selective
use of a retrograde approach is safe, technically feasible at
re-establishing in-line ﬂow to the foot, and can achieve
acceptable limb salvage rates.
Another advantage of this approach is that it uses basic
tools available in the endovascular suite, is less costly than
routine use of CTO and re-entry devices, and can be
achieved with local anesthesia and minimal sedation.
Indeed, re-entry devices were designed to assist in situa-
tions where the antegrade guidewire passes beyond the
CTO but is not able to re-enter the true lumen distal to
the occlusion. Besides cost, a limitation to wide application
of re-entry device use is that they may fail up to 35% of the
time26 in the femoropopliteal location due to inability to
penetrate the occlusion proximally with the antegrade
guidewire or due to perforation. Despite these unique ad-
vantages to the retrograde pedal access, we strongly believe
this type of extreme revascularization technique should be
reserved for patients with CLI, Rutherford chronic limb
ischemia class IV and V, who are otherwise poor candidates
for a tibial bypass. Although we did not note this complica-
tion in our series, given the possibility of obliteration of the
runoff vessel(s) to the foot, a retrograde pedal access
should not be extended into patients with Rutherford
chronic limb ischemia class III/disabling claudication.
CTOs arise from thrombotic occlusion of a high-grade
stenosis; in the coronary artery, histology of an occlusion
has demonstrated a dense concentration of collagen-rich
ﬁbrous tissue proximally and markedly less dense tissue
distally.27 Tibial CTOs likely have less calciﬁed tissue in
the distal segment of the CTO; this is thought to be the ba-
sis for the technical success with retrograde pedal access, as
has also been documented in coronary CTOs.24,28 Another
reason that retrograde access may have an advantage over
antegrade access is that the CTO lesion is closer to the ac-
cess site, which allows for ease of pushability, forward force
through the CTO, and ease of torque delivery. The dorsalis
pedis and posterior tibialis arteries in the foot are ideal ac-
cess arteries for retrograde access. These vessels are super-
ﬁcial even in morbidly obese patients and are readily
visualized by ultrasound guidance, allowing their precise
cannulation. When deciding on which pedal artery to ac-
cess for retrograde recanalization, we favor following the
angiosome concept and selecting the tibial vessel that re-
sults in in-line ﬂow to the tissue loss, because this has
been demonstrated to positively affect limb salvage in pa-
tients with direct compared with indirect ﬂow (86% vs
JOURNAL OF VASCULAR SURGERY
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although it is described in the literature,31 because its
anatomical location in the deep posterior compartment
may result in difﬁculty with postprocedural hemostasis,
increasing the likelihood of hematoma formation and
possible compartment syndrome.
There are some technical aspects that are worth discus-
sing further. First, the retrograde wire should ideally be an
extra support wire that is exchange length (260 cm), allow-
ing ease of treatment with various retrograde balloons or
should snaring of the retrograde wire be required through
an antegrade approach.
Second, sometimes the retrograde wire enters a subin-
timal plane that is in a different subintimal space than the
antegrade wire. In these instances, the dissection mem-
brane that separates both subintimal wires can be disrupted
by a “double-balloon” technique.12 In this technique, a
larger-diameter balloon is used from above and a smaller
balloon distally; both diameters should equal the approxi-
mate size of the vessel being treated. These abutting bal-
loons will disrupt the dissection membrane and allow the
retrograde wire to re-enter the true lumen. Balloon angio-
plasty inﬂation times of 1 minute may be used at half nom-
inal pressures to seal the disrupted membrane and avoid the
need for stent placement.
Third, should a stent be necessary, particularly in a
tibial artery, traditional antegrade access is gained, and
the retrograde wire is brought inside of an antegrade cath-
eter or may be snared through the antegrade approach. A
sirolimus-eluting balloon-expandable stent is used given
preliminary data demonstrating increased efﬁcacy with siro-
limus over paclitaxel.32
Fourth, the pedal access is associated with a learning
curve. It is important for the operator to be comfortable
cannulating a 1- to 2-mm vessel with a single puncture of
the anterior wall of the vessel. Multiple attempts may lead
to vasospasm and potential thrombotic occlusion. Periodic
ﬂushing of the pedal target vessel with a calcium channel in-
hibitor and a direct vasodilator may aid in decreasing the risk
of vasospasm and thrombotic occlusion.
Fifth, as described in the Methods section, it is imper-
ative that the retrograde be performed in a sheathless
fashion and that any balloon catheter brought retrograde
be done so in a “bareback” fashion to avoid pedal vessel
trauma and risk of thrombosis. We have not found the
need to insert a sheath in any of the 13 patients in our
series.
Sixth, routine dual-antiplatelet therapy is used in these
popliteal/tibial interventions as well as statin therapy to
help maintain vessel patency and reduce cardiac morbidity
periprocedurally.33
Lastly, when routine subintimal angioplasty fails during
recanalization attempts of CTOs, a subintimal arterial ﬂoss-
ing with antegrade-retrograde intervention (SAFARI tech-
nique) has been described as a mode of re-entering the true
lumen.6,31 In this technique, retrograde and pedal accesses
are obtained, and retrograde subintimal recanalization is
done until the antegrade subintimal space is reached. Theretrograde wire is then snared or manipulated into an ante-
grade catheter, creating a “ﬂossing-type” wire access. This
facilitates tracking of an angioplasty balloon catheter across
the CTO and treatment.
This is a unique study compared with the case reports
and series that have been reported by nonsurgical groups.
We present patients who were deemed by vascular sur-
geons to be poor surgical candidates and report safety
and intermediate limb salvage data with a mean follow-
up of 17.1 months, longer than what has previously been
reported.
A main limitation of this study is that it is a retrospec-
tive, nonrandomized report from a single institution. The
sample is biased, because this is a small patient population
that was selected to undergo a retrograde pedal access
based on the judgment of one of three vascular surgeons.
Another limitation is that there is no comparison to a
group of patients with Rutherford chronic limb ischemia
class IV or V who were not revascularized through an ante-
grade or retrograde approach. Such a future study would
address the effect of aggressive local wound care on healing
such lesions that cannot be revascularized.
Of the 13 patients in our study, 11 were Rutherford
chronic limb ischemia class V patients. We did not attempt
the retrograde pedal approach on patients with Rutherford
class VI (major tissue loss). Traditionally, we have treated
these patients with a pedal bypass and rotational or free
myocutaneous ﬂaps. Future studies could address the utility
of this technique in this and other patient populations.
Larger scale, multi-institutional studies will need to conﬁrm
the safety, efﬁcacy, and limb salvage rates we have observed.
CONCLUSIONS
Inability to enter the true lumen during an endovascu-
lar intervention involving a popliteal or tibial CTO, or
both, was estimated to occur as high as 20% of the
time,6,21 although this may be lower in more contemporary
practice. Nonetheless, a retrograde pedal approach is
another option for patients with CLI who cannot be revas-
cularized through an antegrade approach and are not tibial
bypass candidates. It can be achieved with minimal
morbidity, avoiding the use of more expensive re-entry de-
vices, and our single-institutional series did not note any
local complications, an understandable fear of using a
retrograde pedal access. More experience with this tech-
nique and further reﬁnement are required for further im-
provements in the treatment of popliteal and tibial CTO
lesions in patients with CLI who are not tibial bypass can-
didates and who cannot be revascularized in an antegrade
manner.
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the authors on this excellent paper about a challenging clinical
and technical problem; namely critical limb ischemia due to tibial
disease in patients who are poor surgical risk.As vascular surgeons, we are increasingly called upon to
achieve limb salvage in more and more difﬁcult situations, be it un-
favorable patient anatomy, patient physiology, or patient physique,
and we need ever-greater numbers of tools in our toolbox in order
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382 Bazan et al August 2014to accomplish this. This paper describes the Ochsner group’s expe-
rience with just such a tool; namely, retrograde pedal access for pa-
tients with tibial artery occlusive disease. While this technique has
been described previously, midterm results have not been reported
previously. The authors describe the use of this technique in pa-
tients in whom a standard antegrade approach had been tried
and had failed, and report favorable technical and clinical success
rates.
I thoroughly enjoyed reading this well-written manuscript and
appreciate receiving it from the authors well in advance of the
meeting. I would also like to thank the authors for providing me
with a copy of the manuscript in a very timely manner. I have
several questions for the authors:
First, can you be more speciﬁc about the unsuitability for sur-
gery? Were there medical comorbidities or patient-related issues
such as obesity? How was this determined? Were there speciﬁc
criteria or was it surgeon-speciﬁc?
Your manuscript suggests that all patients had an initial
attempt at traditional antegrade access. Was this indeed the case,
and if so, was the pedal access attempted at the same or a later
setting?
In four patients, the procedure was technically unsuccessful.
What happened to these patients?
You had a limb salvage rate of 77% at 17 months. Did you
assess patency of the revascularization, and if so, what was it?
Given the results of this study will you change your practice to
offer pedal access as the initial procedure in some cases now?
Dr Hernan Bazan. Thank you, Dr Shortell, for the nice sum-
mary and the very insightful questions. The ﬁrst question you
asked is about the unsuitability of the patients. We did not do
any standardized risk stratiﬁcation. Patient suitability was left to
one of the three board-certiﬁed vascular surgeons who deemed
whether or not the patient was a bypass candidate. Patient factors,such as ischemic cardiomyopathy with a severely depressed ejection
fraction or dialysis-dependence with a poor functional status, are
some examples. In terms of whether or not we brought the pa-
tients back for a retrograde pedal access during the initial angio-
gram, I can only recall one or two instances where the patient
was brought back after a failed antegrade access. This does bring
up another point, which we were discussing earlier: in these cases
that involve a retrograde pedal access after a failed antegrade
approach, what we have found is that after one attempt to revascu-
larized via an antegrade approach for an hour or one hour and a
half, the techs in the endovascular suite are then told “okay, let’s
prep the foot,” and everybody in the endo suite has to be prepared
to work an additional hour or so. Hence, it certainly does add
more time, but I can recall one or two patients where they were
brought back. These were primarily cases in which we were trying
to avoid a large contrast exposure in patients with compromised
renal function.
You also asked a question about the four patients we were not
able to revascularized; there was major limb loss in three of them.
The fourth patient had rest pain, and he subsequently underwent a
successful revascularization through a pedal bypass. He was the
only one out of the 13 that had a bypass, as none of the other pa-
tients were bypass candidates.
The last question you asked: Would this change our practice? I
think, as it was mentioned earlier and mentioned on the ﬁrst day of
our conference, we always teach our trainees to individualize treat-
ment to the patient. I believe we should optimize our attempt to
do a tibial bypass when we can because it is a great operation,
very durable, and to date, nothing else has similar long-term
patency. Although we do in fact attempt an endovascular approach
ﬁrst in the majority of patients, there are some who are clearly
good bypass candidates and no endoluminal attempt at revascular-
ization is made; they go on to a tibial bypass.
